PETERS WILLIAM J 4
4 · Amphastar Pharmaceuticals, Inc. · Filed Nov 8, 2024
Insider Transaction Report
Form 4
PETERS WILLIAM J
DirectorCFO, EVP & TREASURER
Transactions
- Exercise/Conversion
Common Stock
2024-11-06$13.03/sh+7,426$96,761→ 101,529 total - Sale
Common Stock
2024-11-06$52.05/sh−7,426$386,523→ 94,103 total - Exercise/Conversion
Employee Stock Option (right to buy)
2024-11-06−7,426→ 23,674 totalExercise: $13.03Exp: 2030-03-16→ Common Stock (7,426 underlying)
Footnotes (2)
- [F1]The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2024.
- [F2]Shares subject to the option are fully vested and immediately exercisable.